Back story here on the Crestor combo development with Abbott.
What he said:
Tony Zook, AstraZeneca's North American executive vice president, said: "We are excited by the opportunity this collaboration brings to serve an important area of patient need. This represents an important further step in broadening the full, long-term potential of Crestor for the treatment of lipid disorders."
One possible translation:
We are getting our asses kicked by Vytorin and dont have a chance of making the 20% market share we promised the shareholders. A combo is my last hope of keeping my job!
No comments:
Post a Comment